[account_shop_links]
Stay in the know with insight directly from industry experts and decision-makers.
How to Make Your CRO Stand Out or Find that Perfect Fit
Without safe and well-designed clinical trials, drug development would lack necessary direction and evaluation. The industry knows how valuable clinical trials are and so do we. Our reports explore the myriad facets of this dynamic and crucial process to provide…
Predictive Power of Perceived Leadership
The Industry Standard Research CRO Benchmarking reports contain service provider experiences and perspectives from recent users in the biopharmaceutical sphere. This information can inform sponsor organizations to make more educated CRO selections for their Phase I, II, and III studies.…
How Phase I CROs Can Meet Expectations by Understanding Drug Sponsor Needs
Introduction My name is Brian and I’m the VP of Clinical Operations at a global CRO. My job is to ensure our clinical operations team is prepared to meet the demands of our clients. I am also part of a…
COVID Continues to Impact Outsourced Manufacturing and Supply Chain Security
Each of the past three years, Industry Standard Research has included questions in its annual CDMO benchmarking research to better understand whether the pandemic has affected drug innovators’ outsourced manufacturing for small molecule drug substance, small molecule drug product, biologic…
CDMO Performance on Service Provider Selection Criteria
2023 is the 12th year of Life Science Leader’s annual CDMO Leadership Awards, where contract manufacturers are recognized for their ability to deliver above and beyond the expectations of their drug innovator clients. The awards are the result of sponsor…
Phase I Clinical Development and Service Provider Selection
Introduction My name is Shannon and I’m a VP of R&D at a large pharmaceutical company. My job involves creating a clinical development strategy for the next few years, including managing R&D budgets. Another part of my job is to…
Industry Trends: Clinical Trial Logistics Outsourcing
Clinical Trial Logistics Market Dynamics Clinical trials often span numerous sites around the globe and continue to implement more and more decentralized elements, such as in-home visits by healthcare providers. Accordingly, the storage and distribution of clinical trial material has…
Why Are Sponsors Using More Than One CTMS Provider?
In our recent report on clinical trial management systems, CTMS Benchmarking & Market Dynamics (3rd edition), Industry Standard Research explores the evolution of the eClinical market and usage of CTMS in the outsourcing community. Amidst this rapid growth, it can…
Considerations When Selecting an Interactive Response Technology Provider
Interactive response technology (IRT) systems are used to automate supply management, randomization, and analytics for clinical trials. They ensure participants receive the correct treatment at the correct time, allow for enhanced drug supply logistics tracking, and empower users to obtain…
Tracking the Evolution of CDMO Selection Criteria for Biologic Drug Substance Manufacturing
Biologic drug substance developers face an ever-evolving slate of challenges related to CDMO outsourcing. As part of ISR’s CDMO Benchmarking research, respondents are asked to review a list of 28 selection attributes and to identify the one criterion most important…
The Value of Strategic Outsourcing Relationships
The Evolution of Outsourcing Over the past few decades there have been considerable changes in the outsourcing environment; at the outset, pharmaceutical companies were primarily offshoring to lower-cost centers and used different contract manufacturers for different projects in a somewhat…
